reports
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated...
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions. The notes will bear interest at a fixed rate of 8.375% per year until September 12, 2030 (the “First Reset Date”). On and after the Fi...
Moody's Ratings assigns Baa3 rating to Dentsply Sirona's proposed hybr...
Moody's Ratings (Moody's) assigned a Baa3 rating to Dentsply Sirona Inc.'s ("Dentsply Sirona") proposed offering of junior subordinated notes ("hybrid"). At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook ...
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025. Mr. Garth brings nearly 30 years of proven financial management expertise to Dentsply Sirona, with a focus on driving value creation. He most recently served as Chief Financial Officer & Chief Administrative Officer of The Scotts Miracle-Gro Company, a global leader ...
Dentsply Sirona Declares Quarterly Cash Dividend
Dentsply Sirona Declares Quarterly Cash Dividend CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 11, 2025, to holders of record as of June 27, 2025. About Dentsply Sirona Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service t...
- Dave Nicoski
- Ross LaDuke
DXCM DEXCOM INC.
XRAY DENTSPLY SIRONA INC.
WING WINGSTOP INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
UHS UNIVERSAL HEALTH SERVICES INC. CLASS B
STKS ONE GROUP HOSPITALITY
SNPS SYNOPSYS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFST SOUTHERN FIRST BANCSHARES
RGNX REGENXBIO INC.
RCKY ROCKY BRANDS
PRGO PERRIGO CO. PLC
MPWR MONOLITHIC POWER SYSTEMS INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
IRM IRON MOUNTAIN INC.
GPC GENUINE PARTS COMPANY
GD GENERAL DYNAMICS CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CROX CROCS INC.
CAL CALERES INC.
BKE BUCKLE INC.
ASC ARDMORE SHIPPING
AMOT ALLIED MOTION TECHNOLOGIES
ACAD ACADIA PHARMACEUTICALS INC.
SBL SAFE BULKERS INC.
LPG DORIAN LPG
MEG. MEG ENERGY CORP.
MDU MDU RESOURCES GROUP INC
NAT NORDIC AMERICAN TANKERS LIMITED
EVTC EVERTEC INC.
FSLR FIRST SOLAR INC.
IONS IONIS PHARMACEUTICALS INC.
NMIH NMI HOLDINGS INC. CLASS A
AGYS AGILYSYS INC.
SJM J.M. SMUCKER COMPANY
FIZZ NATIONAL BEVERAGE CORP.
NHC NATIONAL HEALTHCARE CORP.
INSW INTERNATIONAL SEAWAYS INC.
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
CELH CELSIUS HOLDINGS INC.
AMD ADVANCED MICRO DEVICES INC.
TTEC TTEC HOLDINGS INC.
AVGO BROADCOM INC.
ST SENSATA TECHNOLOGIES HOLDING PLC
ELAN ELANCO ANIMAL HEALTH INC.
MEC MAYVILLE ENGINEERING
DELL DELL TECHNOLOGIES INC CLASS C
CSTM CONSTELLIUM SE CLASS A
OI O-I GLASS INC
BWMN BOWMAN CONSULTING GROUP LTD
DINO HOLLYFRONTIER CORP
EVEX EVE HOLDING INC
SPXC SPX TECHNOLOGIES INC
WEST WESTROCK COFFEE COMPANY LLC
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
AGEN AGENUS INC.
ARDT ARDENT HEALTH PARTNERS INC
PCT PROVIDENT CAP TR II SKIS 8.75%29
MKTW MARKETWISE INC
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conferen...
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference CHARLOTTE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2025 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 28, 2025, at 9:45 am ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at . About Dentsply Sirona Dentsply Sirona is th...
Dentsply Sirona Reports First Quarter 2025 Results
Dentsply Sirona Reports First Quarter 2025 Results Net sales of $879 million decreased (7.7%), organic sales decreased (4.4%) including a (4.0%) Byte sales impactGAAP gross margin of 53.0%, GAAP net income of $20 million or $0.10 per shareAdjusted gross margin of 56.3%, adjusted EBITDA margin of 19.0%, adjusted EPS of $0.43Maintaining FY25 outlook for organic sales and adjusted EPS; increasing reported sales due to F/X changes CHARLOTTE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results f...
Dentsply Sirona to Host First Quarter Conference Call on May 8th
Dentsply Sirona to Host First Quarter Conference Call on May 8th CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 8, 2025, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company’s we...
Moody's Ratings revises Dentsply Sirona's outlook to negative; affirms...
Moody's Ratings (Moody's) revised Dentsply Sirona Inc.'s ("Dentsply Sirona") outlook to negative from stable. At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The revision of the outlook to negative reflects our v...
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion. David Ferguson joins Dentsply Sirona with 25 years of exp...
Dentsply Sirona Inc: 1 director
A director at Dentsply Sirona Inc bought 15,142 shares at 16.510USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Dentsply Sirona to Participate in the Leerink Partners Global Healthca...
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025 CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 11, 2025, at 3:00 pm ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentsply Si...
- Jonathan Moreland
WWW WOLVERINE WORLD WIDE INC.
TRS TRIMAS CORPORATION
STAA STAAR SURGICAL CO.
SIGI SELECTIVE INSURANCE GROUP INC.
RUN SUNRUN INC.
PBF PBF ENERGY INC. CLASS A
OSUR ORASURE TECHNOLOGIES INC.
LTRX LANTRONIX INC.
KTOS KRATOS DEFENSE & SECURITY SOLUTIONS INC.
GERN GERON CORP.
FSS FEDERAL SIGNAL CORPORATION
APLE APPLE HOSPITALITY REIT INC
DGICA DONEGAL GROUP INC. CL A
KYN KAYNE ANDERSON MLP INVESTMENT CO.
FLWS 1-800-FLOWERS.COM CL A
JELD JELD-WEN HOLDING INC.
FTDR FRONTDOOR INC.
AMCR AMCOR PLC
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
GO GROCERY OUTLET HOLDING
PDSB PDS BIOTECHNOLOGY CORPORATION
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
UTZ UTZ BRANDS INC (A)
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
FLYW FLYWIRE CORP
ECAT BLACKROCK ESG CAP ALLOCATION TR
BNTC BENITEC BIOPHARMA INC
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Pro...
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook FY24 net sales of $3,793 million decreased (4.3%), organic sales decreased (3.5%) including a (1.2%) Byte sales impactFY24 GAAP net loss of ($910) million or ($4.48) per share, adjusted EPS of $1.67Q4 net sales of $905 million decreased (10.6%), organic sales decreased (10.7%) including a (6.0%) Byte sales impactQ4 GAAP net loss of ($430) million or ($2.16) per share, adjusted EPS of $0.26FY25 outlook: net sales in the range of $3.50 billion to $3.60 billion with organic sales down (4.0%) to (...
Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspe...
Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business (“Wellspect”). Wellspect is a leading provider of bladder and bowel management care products with an over 40-year history. Through its comprehensive portfolio of products and accessories from trusted brands like LoFric® and Navina™, Wellspect has delivered...
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Boa...
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the “Board”), effective February 5, 2025. Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company’s digital X-Ray program. Mr. Scavilla, currentl...
Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference C...
Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. A presentation related to the call will be available on the Investors section of the Company’s website at Conference Call / Webcast Information A live webcast will be ava...
Dentsply Sirona Announces Repositioning of Byte within Aligner Portfol...
Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio Company to Present at J.P. Morgan Healthcare Conference CHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the go-to-market business and economic model and expects to leverage collaborative direct-to-consumer (“DTC”) demand generation with dentists using Byte core competencies,...
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare C...
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference CHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 15, 2025, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentsp...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.